The Supreme Court ruled that recommending or advertising specific prescription medicines through a telemedicine app violates the Pharmaceutical Affairs Act even without a profit motive. The court upheld suspended fines of 3 million won each for telemedicine platform Doctor Now and its former chief executive. The ruling makes the legality of prescription-drug promotion depend on the conduct itself, not on whether the platform directly sought financial gain.
